Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression

Acute lung injury (ALI)-triggered pulmonary injury has been associated with high mortality, despite advances in drug treatment and supportive therapy. Remarkable progress has been made in attenuating the inflammatory injury associated with ALI using mesenchymal stem cells (MSCs)-based cell and gene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflammopharmacology
Main Authors: Zhang, Xiaoning, Zhang, Zhiqiang, Ju, Mingyan, Li, Jiaci, Jing, Yaqing, Zhao, Yuxia, Gu, Chao, Dong, Ming, Li, Guang, Liu, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7095386/
https://ncbi.nlm.nih.gov/pubmed/32170527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10787-020-00696-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados